قالب وردپرس درنا توس
Home / Health / Pfizer CEO Albert Bourla called Israel a “world laboratory” in an interview with NBC

Pfizer CEO Albert Bourla called Israel a “world laboratory” in an interview with NBC



Pfizer CEO Albert Burla said: “I believe Israel has now become the world’s laboratory because they only use our vaccines in the state and have vaccinated a large part of the population, so we can study Economic and health index.” An interview with NBC News on Friday.

Bourla said: “We have seen that after the second vaccination, as we speak, the effectiveness of the vaccine in the real world data is improving, so compared with the 14 days after the second vaccination, there are 7 days. The effectiveness is different.”.

When asked whether receiving two doses of the vaccine can infect others, he said: “This needs to be confirmed. The real data we have obtained from Israeli and other studies will help us better understand this.

Burla added: “But now there are many indicators that tell us that there are protective measures to prevent the spread of this disease.”
;

Bourla further pointed out that research on vaccine risks for pregnant women and young children is also ongoing.

“We have issued permits for children 16 years and older… We are already conducting trials for children between 11 and 16 years old. I hope we can get the data within a few months. We also plan to start from 5 years old. Pediatric research has been carried out until the age of 11. I believe that by the end of this year, we should have data on this population.”

Regarding the protection period after receiving two doses of the vaccine, Bola said that the current data show that after six months, this protection effect is very strong, but we need to wait until one year to determine whether it can be retained for the entire year.

The NBC interview also mentioned Israel’s recent research on the effectiveness of vaccines. Bourla pointed out that the data mainly came from the young population. He said that there is still a high risk of relying on only one dose of vaccine to fight the coronavirus. Tobias Siegal contributed to this report.




Source link